The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2Council on Pharmacy and Chemistry (American Medical Association)
Science
The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2
Council on Pharmacy and Chemistry (American Medical Association)
Patent medicines
“As for our regular Taka-Diastase, our claim is and has been for
years simply that Taka-Diastase will digest or hydrolyze 150 times
its weight of starch in ten minutes, under proper conditions. We
do not claim, we do not permit our representatives to claim, that
Taka-Diastase will completely transform starch, to the colorless
end-point, into sugars. Taka-Diastase is used to supplement a
deficiency of ptyalin and converts the starch into soluble material
with great rapidity, thus giving the gastric fluid immediate access
to the proteids.
“If in the enclosed labels the word ‘digest’ were replaced with the
word ‘liquefy,’ the claim could not be assailed by the most carping
critic. To save any possible question, we shall therefore make this
change in our label, having it read: ‘Taka-Diastase will liquefy 150
times its weight of starch in ten minutes, under proper conditions.’
Is there the slightest question in your mind that this statement as
just quoted is entirely correct and entirely supported by clinical
experience?
“It is our conviction that Taka-Diastase has a very remarkable power
to hydrolyze starch either in the test-tube or in the stomach, and
that this property is of great utility in clinical work. We do not
claim that its conversion of the starch into sugars is complete, to
the colorless end-point of the Johnson test; and on this point we
have been perfectly frank with the Council, as well as with every
physician who has taken sufficient interest to inquire.”
In view of the above protest, the matter was submitted to a second
referee, who reported as follows:
“Your referee on the matter of Taka-Diastase has made a careful
investigation of the reports and correspondence submitted, and begs
to make the following report:
“The question at issue, viz., whether Taka-Diastase should be
included in New and Nonofficial Remedies, I believe, can be
determined by the material before me, and further tests of the
material are not necessary.
“The letter of the makers of Taka-Diastase admits that the early
claims regarding the strength and properties of the material were
erroneous and exaggerated. Since the product was once admitted to New
and Nonofficial Remedies, it may be claimed that as the Council on
Pharmacy and Chemistry must have been in error then, it may be now.
Your referee does not consider this supposition worth discussing. The
conclusion he draws is that the Council was too hasty in accepting
the preparation, and that the incident shows how much better it would
be in all cases to accept no remedy until sufficient time has been
given for conclusive tests.
Public-domain text, read in full here on John Shaqi.
Reviews
Reviews
No reviews yet
Be the first to share your thoughts on this work.
Elsewhere in the archive
Join the Discussion
Join the discussion
Sign in to leave a comment or review.
Sign InorCreate an account